Records containing: Multiple Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-12-24A Phase I Study of GRN163L in Combination With Bortezomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-12-18An Open-Label, Dose-Escalation, Phase 1/2 Study of the Oral Formulation of IXAZOMIB (MLN9708), Administered Twice-weekly in Combination With Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Requiring Systemic Treatment
-
CLINICAL_TRIALS study record update · 2015-12-11A Randomized, Open-label, Phase 3 Study of Carfilzomib Plus Dexamethasone vs. Bortezomib Plus Dexamethasone in Patients With Relapsed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-12-09Phase 1b/2, Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors, Multiple Myeloma or Lymphoma
-
CLINICAL_TRIALS study record update · 2015-12-09Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-12-08A Randomized, Open-label Phase III Study of Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Combination With Standard Therapy in Patients With Newly Diagnosed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-12-08Phase 0 Microdose Study to Evaluate the Effect of Melphalan, Bortezomib and Dexamethasone on Cellular Gene-expression in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-12-07Phase 2/3 Randomized, Open-Label Clinical Trial of Tanespimycin (KOS-953) Plus Bortezomib Comparing Three Doses of Tanespimycin in Patients With Relapsed-Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-12-03A Phase I Study of the Safety and Pharmacokinetics of Escalating Intravenous Doses of the Proteasome Inhibitor PR-171 in Patients With Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2015-12-03An Open-label, Single-arm, Phase 2 Study of Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-12-02An International Single-Arm Study to Provide Further Safety and Efficacy Data on the Bortezomib(Velcade)/Melphalan/Prednisone Regimen in Previously Untreated Transplant Ineligible Multiple Myeloma Patients
-
CLINICAL_TRIALS study record update · 2015-11-30Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
-
CLINICAL_TRIALS study record update · 2015-11-20Pilot Study of Geriatric Assessments in Senior Adults With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-11-17B-Receptor Signaling in Cardiomyopathy
-
CLINICAL_TRIALS study record update · 2015-11-13C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT for Staging and Response Assessment
-
CLINICAL_TRIALS study record update · 2015-11-10A Phase 2, Multicenter, Single-arm, Open-label Study in Japan to Evaluate the Efficacy and Safety of Pomalidomide (CC-4047) in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-11-10MT2008-15: Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematological Malignancies Using a Nonmyeloablative Preparative Regimen and Priming With Complement 3a Fragment (C3a)
-
CLINICAL_TRIALS study record update · 2015-11-04A Multicenter Randomized Open Label Phase II Study of Pomalidomide and Dexamethasone in Relapse and Refractory Multiple Myeloma Patients Who Are Progressive and Did Not Achieve at Least a Partial Response to Bortezomib and Lenalidomide
-
CLINICAL_TRIALS study record update · 2015-11-04An Open-label, Single-arm, Phase 1b/ 2 Study of Carfilzomib in Combination With Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-10-26Compassionate Use Study of Carfilzomib for Patients With Relapsing or Resistant Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-10-26UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2015-10-23A Multicenter, Randomized, Double Blind, Placebo Controlled Phase III Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-10-21A Phase 2 Study Incorporating Bone Marrow Microenvironment (ME) Co-Targeting Bortezomib Into Tandem Melphalan-Based Autotransplants With DT PACE for Induction/Consolidation and Thalidomide + Dexamethasone for Maintenance
-
CLINICAL_TRIALS study record update · 2015-10-14Phase I Evaluation of Interferon-alpha-1b in Solid Tumors, Lymphoma or Myeloma
-
CLINICAL_TRIALS study record update · 2015-10-12A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma